Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Draghi or Lagarde: A Meaningful Difference for Gold?

In November, Christine Lagarde will replace Mario Draghi as the ECB President. Will gold warm up to her more than to Draghi? It remains to be seen, but one thing is certain: Super Mario will not leave his position just like that. Gold investors should be prepared for his Grand...
Arkadiusz Sieron | July 23, 2019 |

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings

Avadel Pharmaceuticals' shares traded 25% higher reaching a new 52-week high price after the company reported positive topline results from its Pivotal Phase 3 REST-ON trial of FT218 for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. ...
Streetwise Reports | April 28, 2020 |

Dangerous Strength in the Gold Stocks

We previously wrote about the situation being similar to 2012 with regard to overall price movement in gold and in particular with regard to the 61.8% Fibonacci retracement that has been just reached. The yellow metal declined by a few dollars yesterday, just like it did after...
Przemyslaw Radomski, CFA | March 27, 2019 |

Falcon Gold Buys Newfoundland Gold Project as CEO Karim Rayani Backs Company in the most Meaningful

On July 13, 2021 Falcon Gold (FG.V) announced that it has acquired a significant land position within the Hope Brook Area, Newfoundland . Falcon Gold has de-risked itself significantly by acquiring and developing multiple projects in multiple jurisdictions. That is a...
Lukas Kane | July 14, 2021 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |

Pursuing silver and gold acquisitions from a position of strength

Silvercorp Metals Inc. has developed a knack for replicating a profitable mining strategy globally By Peter Kenter Every precious metal mining company is looking for the next great gold or silver property. Silvercorp Metals Inc. ( TSX:SVM / NYSEAM: SVM ) is no...
Research | January 30, 2023 |

Top Pick Status Given to Small-Cap with Pain Drug Candidate

The primary reason for the rating—upcoming trial results—is discussed in an Echelon Wealth Partners report. In a July 10 research note, analyst Douglas Loe reported that Echelon Wealth Partners bestowed Top Pick status on Antibe Therapeutics Inc. (ATE:TSX.V...
Streetwise Reports | July 19, 2019 |

Allakos Shares Double on AK002 Phase 2 Results and Earnings

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. Clinical stage biotech company Allak...
Streetwise Reports | August 7, 2019 |

Foot Locker Shares Trip and Fall on Lower Than Expected Earnings

Foot Locker Inc. shares set a 52-week intraday low after the firm reported Q2/19 earnings. The firm's shares are trading down more than 18% compounded by a day of market worries from China tariffs escalation. Global specialty athletic retailer Foot Locker Inc. (FL:NY...
Streetwise Reports | August 26, 2019 |

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data

Shares of Aurinia Pharmaceuticals traded much higher today after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20. Yesterday afternoon, Vi...
Streetwise Reports | December 7, 2019 |
1 2 3 4 5 6 7 8 9 10 ...